Conference Debates Strategic Patenting, Innovation & Public Health 21/05/2010 by Monika Ermert for Intellectual Property Watch Leave a Comment MUNICH – Whether strengthening patent protection and extending data exclusivity is the way to more innovation in the pharmaceutical and diagnostic sector was the subject of a recent conference here.
WHO’s Precious Matsoso On Public Health, Innovation And Intellectual Property 20/05/2010 by Intellectual Property Watch Leave a Comment The annual World Health Assembly is considering how to take forward a 2008 landmark decision at the World Health Organization that approved a new Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Precious Matsoso, the current director of the WHO programme, spoke to Intellectual Property Watch in April about the ongoing implementation of the strategy, and what is needed to keep momentum going.
Brazilian Generic Drug Registration Sets Standard For ‘Pipeline’ Patents 13/05/2010 by Claudia Jurberg for Intellectual Property Watch 5 Comments The first Brazilian generic drug against erectile dysfunction recently received registration at the National Surveillance Agency – a unit of the Health Ministry. The Viagra generic’s registration was only possible because of a decision of the Superior Court that will terminate the drug patent next month, said Odnir Finotti, president of the Pro-Generics Association.
May Edition Of IP-Watch Monthly Reporter Now Available 11/05/2010 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The May edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.
US, WIPO Officials Assess Patent Reform, PCT, Copyright Priorities 10/05/2010 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment NEW YORK – Republican and Democratic lawmakers in the United States are “hotlining” colleagues to ascertain if there is any objection to moving patent reform quickly through the US Senate, a representative of a major stakeholder in the debate said here Friday. Meanwhile, the US Copyright Office is working to get its priorities through a restructured Congress, and a World Intellectual Property Organization official warned of a possible divide in WIPO’s norm-setting activities.
A Prescription For Failure — Health And IP In The Dominican Republic 03/05/2010 by Intellectual Property Watch 1 Comment In the United States, trade policy is generally considered an economic issue. But for developing countries like the Dominican Republic, it can be a matter of life and death, write Tanya Baytor and Patrick Griffith of Georgetown University Law Center.
Global IP Enforcement Push Impacting Consumer Access, 2010 IP Watchlist Finds 29/04/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment The second edition of the Consumers International IP Watchlist has been published, with the conclusion that consumers are bearing collateral damage to the enforcement push by entertainment and media lobby groups encouraging stringent national legislations. Copyright laws and enforcement are changing, but mostly for the benefit of right holders, said the advocate group which encourages copyright exceptions.
《国家标准涉及专利的处置规则》最新稿：是不是向前一步？ 29/04/2010 by Intellectual Property Watch Leave a Comment 2010年一月21日，中国标准化研究院1发布了《国家标准涉及专利的处置规则2（征求意见稿）》（简称《处置规则》)，向有利益关系的参与者征求意见。此《处置规则》为国家标准化管理委员会《涉及专利的国家标准制修订管理规定（暂行）（征求意见稿）》（简称《修订管理规定》)重要成分之一。3
EU-India Trade Talks Resume Under Cloud Of Concern For Public Health 27/04/2010 by Monika Ermert for Intellectual Property Watch 1 Comment BRUSSELS – Negotiations on the EU-India free trade agreement continue tomorrow in Brussels amid warnings from non-governmental organisations from India and Europe about possible negative consequences for the public health of poor citizens in India. But European negotiators sought to assuage fears.
Medicrime: Another Anti-Counterfeiting Convention Emerges In Europe 24/04/2010 by Monika Ermert for Intellectual Property Watch 3 Comments While the Anti-Counterfeiting Trade Agreement (ACTA) is getting a lot of attention with its draft consolidated version just published, there is another convention dealing with one major aspect it was always said ACTA would tackle. The Medicrime Convention of the Council of Europe sets the first international standard for criminalising the manufacturing and distribution of counterfeited medicine risking public health. And Medicrime will overtake ACTA, as the draft convention text is ready to be signed by the Committee of Ministers in May and be opened for signature in November.